| |
| | Richard J. Johnson, M.D. - Department of Medicine (Site not responding. Last check: 2007-10-31) |
 | | Kang D-H, Hughes J, Mazzali M, Schreiner GF, and Johnson RJ: Impaired angiogenesis in the remnant kidney model (II): VEGF administration reduces renal fibrosis and stabilizes renal function. |
 | | Mazhar AR, Johnson RJ, Gillen D, Stivelman JC, Ryan MJ, Davis CL and Stehman-Breen CO. Risk factors and mortality associated with calciphylaxis in end-stage renal disease. |
 | | Tallquist MD, Klinghoffer RA, Heuchel R, Mueting-Nelsen, PF, Corrin PD, Heldin C-H, Johnson RJ, Soriano P. Retention of PDGFRb function in mice in the absence of phosphatidylinositol-3 kinase and phospholipase Cg signaling pathways. |
| public.bcm.tmc.edu /medicine/renal/renalfac/johnson.htm (387 words) |
|